ProfileGDS4177 / 235648_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 84% 84% 85% 89% 83% 85% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated289.6584
GSM603099KU-812 non-treated293.8784
GSM603098KCL-22 Imatinib-treated315.8685
GSM603097KCL-22 non-treated468.5289
GSM603102JURL-MK1 Imatinib-treated269.6283
GSM603101JURL-MK1 non-treated306.7285